Muehlematter, Urs J.
Nagel, Hannes W.
Becker, Anton
Mueller, Julian
Vokinger, Kerstin N.
de Galiza Barbosa, Felipe
ter Voert, Edwin E. G. T.
Veit-Haibach, Patrick
Burger, Irene A.
Article History
Received: 16 January 2018
Accepted: 18 April 2018
First Online: 31 May 2018
Change Date: 27 July 2018
Change Type: Correction
Change Details: Unfortunately, after publication of this article [1], it was noticed that the name of Urs J. Muehlematter was incorrectly displayed as Urs J. Mühlematter. The corrected author list can be seen above and the original article has been corrected to reflect this.
Ethics approval and consent to participate
: This study was approved by the institutional review board (local ethics committee, KEK ZH-Nr 2013-0220). Informed consent was obtained from each patient prior to the study inclusion and to the PET/MRI.
: The Department of Nuclear Medicine holds an institutional Research Contract with GE Healthcare. Author IAB has received research grants and speaker honorarium from GE Healthcare and Swiss Life. Author IAB received speaker honorarium from Bayer Health Care and Astellas Pharma AG. Patrick Veit-Haibach received investigator-initiated study grants from Bayer Healthcare, Siemens Healthcare, Roche Pharmaceuticals, GE Healthcare, and speaker’s fees from GE Healthcare. Authors UJM, HWN, AB, JM, KNV, FdGB, and EEGWtV declare no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.